PMS-FLUTICASONE PROPIONATE/SALMETEROL DPI

Pharmascience Inc🇨🇦 Health Canada

Approval Id: 675addfea132434e
Drug Approval Canada Name: PMS-FLUTICASONE PROPIONATE/SALMETEROL DPI
Product Name: PMS-FLUTICASONE PROPIONATE/SALMETEROL DPI
Status: Marketed
Status Date: 2020-03-05
Original Market Date: 2020-03-05
Din: 02494507
Drug Class: Human
Dosage Form: Powder
Route Of Administration: Inhalation
Schedule: Prescription
Ahfs: 12:12.08.12
Atc Original: R03AK06 SALMETEROL AND FLUTICASONE
Atc Name: r 03 ak 06
Aig Number: 0238341001
Company Name: Pharmascience Inc
Company Address: 100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path: /organization/pharmascience-inc

FLUTICASONE PROPIONATE

100 MCG / ACT

SALMETEROL (SALMETEROL XINAFOATE)

50 MCG / ACT

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

675addfea132434e

Type

Standard